We found that Gabapentin most likely acts through STAT1 and TLR7 to achieve anti-tumor effects by altering the immune infiltration content of TILs such as CD8+ T cells in TME to inhibit the proliferation and invasion of CM cells using molecular docking analysis and a summary of key molecules mentioned above. Here, STAT1 is linked to neoplasm.